Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Ferozsons Laboratories Ltd (FERO)

Karachi
Currency in PKR
Disclaimer
222.50
-3.58(-1.58%)
Closed
FERO Scorecard
Fair Value
Unlock Value
Day's Range
222.50227.00
52 wk Range
132.56256.49
Bid/Ask
222.50 / 222.50
Prev. Close
226.08
Open
225.01
Day's Range
222.5-227
52 wk Range
132.56-256.49
Volume
46,890
Average Vol. (3m)
90,195
1-Year Change
62.09%
Shares Outstanding
43,469,051
Fair Value
Unlock
Dividends Payment Streak
Unlock
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
How do you feel today about FERO?
Vote to see community's results!
or

Ferozsons Laboratories Ltd Company Profile

Ferozsons Laboratories Limited, together with its subsidiaries, engages in the importing, manufacturing, and sale of pharmaceutical products and medical devices in Pakistan and internationally. The company offers products in various therapeutic areas of anti-fungal, diabetes, anti-viral, cardiometabolic, cough, dermatology, orthopaedic, urology and nephrology, gastrointestinal and liver, antibiotics, and oncology areas. It also provides medical devices in the areas of cardiology, G.I. endoscopy, oncology, peripheral vascular disease, urology, and women's health applications. In addition, the company has collaborations with Bagó Group; Biofreeze; BioGaia; and Gilead Sciences, Inc. Ferozsons Laboratories Limited was incorporated in 1954 and is headquartered in Lahore, Pakistan.

Employees
1545
Market
Pakistan
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.